As of 12:28PM EDT. Market open. BOTHELL, Wash., September 13, 2024--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer ...
Some results have been hidden because they may be inaccessible to you